Zaloguj się

Gotowe bibliografie tematyczne / BRCA1 / Książki

Książki na temat „BRCA1”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: BRCA1.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 10 marca 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „BRCA1”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Winter, Sherry Lynn. Identification of BRCA1 interacting proteins. Ottawa: National Library of Canada, 2000.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Canadian Coordinating Office for Health Technology Assessment., red. A clinical systematic review of BRCA1 and BRCA2 genetic testing for breast and ovarian cancers. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

National Institutes of Health (U.S.). Clinical Center i National Institutes of Health (U.S.). Office of Clinical Center Communications, red. Answers to your questions: Testing for BRCA1. [Bethesda, Md.?]: The Warren Grant Magnuson Clinical Center, 1996.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

National Institutes of Health (U.S.). Clinical Center. i National Institutes of Health (U.S.). Office of Clinical Center Communications., red. Answers to your questions: Testing for BRCA1. [Bethesda, Md.?]: The Warren Grant Magnuson Clinical Center, 1996.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Lynda, McGahan, i Canadian Coordinating Office for Health Technology Assessment, red. BRCA1 and BRCA2 predictive genetic testing for breast and ovarian cancers: A systematic review of clinical evidence. Ottawa: CCOHTA, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Reczek, Colleen Renee. The Role of CtIP in BRCA1-Mediated Tumor Suppression. [New York, N.Y.?]: [publisher not identified], 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Reid, Latarsha. Analysis of The RING Domain And BRCT Repeats of BRCA1. [New York, N.Y.?]: [publisher not identified], 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Gabriel, Sarah. Eating pomegranates: A memoir of mothers, daughters, and the BRCA gene. New York: Scribner, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Gabriel, Sarah. Eating pomegranates: A memoir of mothers, daughters and genes. Rearsby: Clipper Large Print, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

H, Lu Karen, red. Hereditary gynecologic cancer: Risk, prevention, and management. New York: Informa Healthcare, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Gabriel, Sarah. Eating pomegranates: A memoir of mothers, daughters, and the BRCA gene. New York: Scribner, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

B. Chagpar, Anees, red. Managing BRCA Mutation Carriers. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-59198-8.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Gerhardus, Ansgar, Henriette Schleberger, Brigitte Schlegelberger i Friedrich Wilhelm Schwartz, red. BRCA — Erblicher Brust- und Eierstockkrebs. Berlin/Heidelberg: Springer-Verlag, 2005. http://dx.doi.org/10.1007/b137779.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Herrlinger, Karolina Anna. Die Patentierung von Krankheitsgenen: Dargestellt am Beispiel der Patentierung der Brustkrebsgene BRCA 1 und BRCA 2. Köln: Heymanns, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

1966-, Gordon Ora Karp, red. Positive results: Making the best decisions when you're at high risk for breast or ovarian cancer. Amherst, N.Y: Prometheus Books, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Blood matters: A journey along the genetic frontier. London: Granta, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

author, Gosline Diana, i Smith Diana author, red. Deleterious: A Mutant Gene Zine. Portland, OR: the authors, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Ionescu, Daniela. Protein-protein interactions between the breast cancer susceptibility gene product BRCA2 and replication protein A. Ottawa: National Library of Canada, 1999.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Genetic testing for breast and ovarian cancer risk: It's your choice. Wyd. 2. Bethesda, Md.]: U.S. Dept. of Health and Human Services, National Institutes of Health, National Cancer Institute, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Legacy for Donna: A palliative death full of blessings : a plea for preventive health genealogies. Durham, CT: Eloquent Books, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

From the feet up. Wyd. 2. North Sydney, N.S.W: Harlequin Mira, 2014.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Drugs for HER2-positive breast cancer. Basel: Springer, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

service), SpringerLink (Online, red. The Role of Genetics in Breast and Reproductive Cancers. New York, NY: Springer Science+Business Media, LLC, 2010.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

BRCA1 and BRCA2 Mutations - Diagnostic and Therapeutic Implications [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.100842.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Mark, Wen-Ying. Domain characterization of human BRCA1. 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Mark, Wen-Ying. Domain characterization of human BRCA1. 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Firth, Helen V., Jane A. Hurst i Judith G. Hall. Cancer. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780192628961.003.0156.

Pełny tekst źródła

Streszczenie:

BRCA1 and BRCA2 426Breast cancer 430Cancer surveillance methods 434Colorectal cancer (CRC) 436Confirmation of diagnosis of cancer 440Cowden syndrome (CS) 442Familial adenomatous polyposis (FAP) 444Gastric cancer 450Gorlin syndrome 452Hereditary nonpolyposis colorectal cancer (HNPCC) 454Juvenile polyposis syndrome (JPS) ...

Style APA, Harvard, Vancouver, ISO itp.

28

Gibson, Lianne Mary. Functional interactions of tumor suppressors Brca1 and Mus81. 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Kwon, Rachel J. Breast Cancer after Prophylactic Bilateral Mastectomy in Patients with BRCA Mutation. Redaktorzy Patrick Borgen i Miguel A. Burch. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199384075.003.0024.

Pełny tekst źródła

Streszczenie:

This chapter provides a summary of a landmark study in breast surgical oncology. Does prophylactic bilateral mastectomy reduce the incidence of breast cancer in patients with BRCA1 or BRCA2 mutation? Starting with that question, it describes the basics of the study, including funding, year study began, year study was published, study location, who was studied, who was excluded, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. The chapter briefly reviews other relevant studies and information, gives a summary and discusses implications, and concludes with a relevant clinical case involving the possibility of prophylactic bilateral mastectomy for breast cancer.

Style APA, Harvard, Vancouver, ISO itp.

30

Ali-Fehmi, Rouba, i Eman Abdulfatah. Biological Aspects and Clinical Applications of Serum Biomarkers in Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0002.

Pełny tekst źródła

Streszczenie:

Ovarian cancer, the most aggressive gynecological malignancy, presents at advanced stages with metastatic disease. Diagnosis at an early stage is the most important determinant of survival; however, the majority of patients are asymptomatic at early stages and the current diagnostic tools used in clinics show limited success in early detection and hence the need for new diagnostic biomarkers. With the advance of techniques in genomic and proteomics, numerous biomarkers are emerging which may serve as a platform for early detection of ovarian cancer. These include gene-, protein-, miRNAs, and metabolite- based biomarkers. Examples of gene-based biomarkers include HE4, FLOR1, p16INK4a, BRCA1, BRCA2, MLH1, and MSH2. Protein- based biomarkers include leptin, prolactin, osteopontin, IGF-II, and MIF. This chapter discusses the serum tumor markers (CA-125) in current use for screening, diagnosis and monitoring of ovarian cancer as well as the novel biomarkers that are under investigation and validation.

Style APA, Harvard, Vancouver, ISO itp.

31

Lu, Karen H. Hereditary Gynecologic Cancer: Risk, Prevention and Management. Taylor & Francis Group, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Lu, Karen H. Hereditary Gynecologic Cancer: Risk, Prevention and Management. Taylor & Francis Group, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

GIBBON, SAHRA, Jessica Mozersky, Andrea zur Nieden, Galen Joseph i Sonja Palfner. Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. Taylor & Francis Group, 2014.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. Taylor & Francis Group, 2014.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of Brca. Routledge, 2014.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

GIBBON, SAHRA, Jessica Mozersky, Andrea zur Nieden, Galen Joseph i Sonja Palfner. Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. Taylor & Francis Group, 2014.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Weberpals, Johanne Ingrid. The role of the BRCA1-dependent DNA repair pathway in the pathogenesis of non-hereditary epithelial ovarian cancer. 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Weberpals, Johanne Ingrid. The role of the BRCA1-dependent DNA repair pathway in the pathogenesis of non-hereditary epithelial ovarian cancer. 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Hereditary Gynecologic Cancer: Risk, Prevention and Management. Informa Healthcare, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Pandora's DNA: Tracing the Breast Cancer Genes Through History, Science, and One Family Tree. Chicago Review Press, Incorporated, 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Stark, Lizzie. Pandora's DNA: Tracing the Breast Cancer Genes Through History, Science, and One Family Tree. Chicago Review Press, Incorporated, 2014.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Pandora's DNA: Tracing the breast cancer genes through history, science, and one family tree. Chicago Review Press, 2014.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Stark, Lizzie. Pandora's DNA: Tracing the Breast Cancer Genes Through History, Science, and One Family Tree. Chicago Review Press, Incorporated, 2014.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Schleberger, Henriette, Brigitte Schlegelberger, Ansgar Gerhardus i Friedrich W. Schwartz. BRCA - Erblicher Brust- und Eierstockkrebs: Beratung - Testverfahren - Kosten. Springer London, Limited, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

(Editor), Ansgar Gerhardus, Henriette Schleberger (Editor), Brigitte Schlegelberger (Editor) i Friedrich W. Schwartz (Editor), red. BRCA - Erblicher Brust- und Eierstockkrebs: Beratung - Testverfahren - Kosten. Springer, 2005.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Gessen, Masha. Blood Matters: From BRCA1 to Designer Babies, How the World and I Found Ourselves in the Future of the Gene. Houghton Mifflin Harcourt Trade & Reference Publishers, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Gessen, Masha. Blood Matters: From BRCA1 to Designer Babies, How the World and I Found Ourselves in the Future of the Gene. Houghton Mifflin Harcourt Trade & Reference Publishers, 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Winter, Sherry Lynn. Genetic and functional characterization of the interaction of BRCA1 with the serine/threonine phosphatase, PP1, and the circadian clock proteins, Per1 and Per2. 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Chagpar, Anees B. Managing BRCA Mutation Carriers. Springer, 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Chagpar, Anees B. Managing BRCA Mutation Carriers. Springer International Publishing AG, 2017.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!